Description:
Axenoll® owns the worldwide licensing rights for cellular and molecular 3D bioprinting in cleanroom R&D, manufacturing and commercialisation using the patented Exentis 3D Mass Customisation® and Exentis 3D Screen Printing technologies.
Keywords:
Axenoll 3D Printing Jena,FUSE-AI Hamburg,